Delivery Order SPE2DR25D1002-SPE2DR26FGN0S
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,625.76 to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units. This is a firm fixed-price, non-set-aside contract with performance to be completed by July 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,767.72 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count packaging. This is a firm fixed-price, non-set-aside contract with performance expected to conclude by January 8, 2026, and the work will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,411.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion in 60-unit quantities, with performance in Conshohocken, Pennsylvania and completion targeted for September 24, 2025. This non-set-aside contract represents a competitive award under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit quantities. This is a firm fixed-price delivery order valued at $1,344.96, with an ultimate completion date of September 22, 2025. The award is not set-aside and represents a competitive procurement of pharmaceutical products for federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $10,114.72 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 count) on September 15, 2025, with a completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion in 30-count packages, valued at $3,309.99. The contract, awarded on October 28, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of October 29, 2025. This non-set-aside award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 count) with a ceiling value of $2,072.32. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion in 30-count units, valued at $3,474.29, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The product will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,036.72 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 count) under a firm fixed price contract. The award was issued on November 4, 2025, with an ultimate completion date of November 5, 2025, and represents a non-set-aside competitive procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 single-dose units) with a ceiling value of $5,664.59. This competitively awarded, firm fixed-price delivery order is set to be completed by December 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGN0SDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,156.56 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% eye emulsion in 60-unit containers, with an ultimate completion date of January 21, 2026. This is a firm fixed-price, non-set-aside contract issued on January 20, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's established capability to meet federal procurement requirements through competitive, open contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/19/26 |